Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in nuclei raphe and caudate-putamen during physostigmine-induced tremor in rats

Hina Mehta, Bobby Thomas, Kochupurackal P. Mohanakumar

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The biochemical mechanism underlying tremor is unknown. We investigated the effects of p-chlorophenylalanine (pCPA), a serotonin (5-HT) depletor, on the neurochemical processes in nuclei raphe dorsalis (NRD) and caudatus putamen (NCP) paralleling physostigmine-induced tremor in rats. Peak of physostigmine tremor correlated with increase in 5-HT in NRD and NCP, and a decrease in striatal dopamine (DA), as assayed employing high pressure liquid chromotography-electrochemistry. Administration of pCPA caused significant decrease in DA, norepinephrine (NE) and 5-HT levels in both the nuclei, without affecting striatal NE content and acetylcholinesterase activity. pCPA pretreatment significantly inhibited physostigmine-induced tremor and blocked corresponding increase in the levels of 5-HT in NRD and NCP. These results indicate involvement of central 5-HT, but not DA or NE, in the genesis of physostigmine tremor.

Original languageEnglish (US)
Pages (from-to)105-108
Number of pages4
JournalNeuroscience Letters
Volume299
Issue number1-2
DOIs
StatePublished - Feb 16 2001

Fingerprint

Fenclonine
Corpus Striatum
Physostigmine
Raphe Nuclei
Biogenic Amines
Caudate Nucleus
Putamen
Tremor
Acetylcholinesterase
Serotonin
Dopamine
Norepinephrine
Electrochemistry
Pressure
Dorsal Raphe Nucleus

Keywords

  • Dopamine
  • Motor dysfunction
  • Norepinephrine
  • Serotonin (5-HT) mediation of tremor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in nuclei raphe and caudate-putamen during physostigmine-induced tremor in rats. / Mehta, Hina; Thomas, Bobby; Mohanakumar, Kochupurackal P.

In: Neuroscience Letters, Vol. 299, No. 1-2, 16.02.2001, p. 105-108.

Research output: Contribution to journalArticle

@article{62f0e4f3a39b4433b7269e910b2c36f3,
title = "Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in nuclei raphe and caudate-putamen during physostigmine-induced tremor in rats",
abstract = "The biochemical mechanism underlying tremor is unknown. We investigated the effects of p-chlorophenylalanine (pCPA), a serotonin (5-HT) depletor, on the neurochemical processes in nuclei raphe dorsalis (NRD) and caudatus putamen (NCP) paralleling physostigmine-induced tremor in rats. Peak of physostigmine tremor correlated with increase in 5-HT in NRD and NCP, and a decrease in striatal dopamine (DA), as assayed employing high pressure liquid chromotography-electrochemistry. Administration of pCPA caused significant decrease in DA, norepinephrine (NE) and 5-HT levels in both the nuclei, without affecting striatal NE content and acetylcholinesterase activity. pCPA pretreatment significantly inhibited physostigmine-induced tremor and blocked corresponding increase in the levels of 5-HT in NRD and NCP. These results indicate involvement of central 5-HT, but not DA or NE, in the genesis of physostigmine tremor.",
keywords = "Dopamine, Motor dysfunction, Norepinephrine, Serotonin (5-HT) mediation of tremor",
author = "Hina Mehta and Bobby Thomas and Mohanakumar, {Kochupurackal P.}",
year = "2001",
month = "2",
day = "16",
doi = "10.1016/S0304-3940(01)01507-5",
language = "English (US)",
volume = "299",
pages = "105--108",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in nuclei raphe and caudate-putamen during physostigmine-induced tremor in rats

AU - Mehta, Hina

AU - Thomas, Bobby

AU - Mohanakumar, Kochupurackal P.

PY - 2001/2/16

Y1 - 2001/2/16

N2 - The biochemical mechanism underlying tremor is unknown. We investigated the effects of p-chlorophenylalanine (pCPA), a serotonin (5-HT) depletor, on the neurochemical processes in nuclei raphe dorsalis (NRD) and caudatus putamen (NCP) paralleling physostigmine-induced tremor in rats. Peak of physostigmine tremor correlated with increase in 5-HT in NRD and NCP, and a decrease in striatal dopamine (DA), as assayed employing high pressure liquid chromotography-electrochemistry. Administration of pCPA caused significant decrease in DA, norepinephrine (NE) and 5-HT levels in both the nuclei, without affecting striatal NE content and acetylcholinesterase activity. pCPA pretreatment significantly inhibited physostigmine-induced tremor and blocked corresponding increase in the levels of 5-HT in NRD and NCP. These results indicate involvement of central 5-HT, but not DA or NE, in the genesis of physostigmine tremor.

AB - The biochemical mechanism underlying tremor is unknown. We investigated the effects of p-chlorophenylalanine (pCPA), a serotonin (5-HT) depletor, on the neurochemical processes in nuclei raphe dorsalis (NRD) and caudatus putamen (NCP) paralleling physostigmine-induced tremor in rats. Peak of physostigmine tremor correlated with increase in 5-HT in NRD and NCP, and a decrease in striatal dopamine (DA), as assayed employing high pressure liquid chromotography-electrochemistry. Administration of pCPA caused significant decrease in DA, norepinephrine (NE) and 5-HT levels in both the nuclei, without affecting striatal NE content and acetylcholinesterase activity. pCPA pretreatment significantly inhibited physostigmine-induced tremor and blocked corresponding increase in the levels of 5-HT in NRD and NCP. These results indicate involvement of central 5-HT, but not DA or NE, in the genesis of physostigmine tremor.

KW - Dopamine

KW - Motor dysfunction

KW - Norepinephrine

KW - Serotonin (5-HT) mediation of tremor

UR - http://www.scopus.com/inward/record.url?scp=0035895780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035895780&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(01)01507-5

DO - 10.1016/S0304-3940(01)01507-5

M3 - Article

C2 - 11166949

AN - SCOPUS:0035895780

VL - 299

SP - 105

EP - 108

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -